Lina Khan @linamkhan · 20 Dec 2024
1. Today the Federal Circuit rejected Teva's bid to list device patents for inhalers in the Orange Book. Practically this means that drug makers can't list patents for things like inhaler caps to block generic rivals from the market & keep prices high. A big win for Americans.
1 391 171Views
15 586Likes
2 995Reposts
324Replies
185Quotes
926Bookmarks
Is that a lot?
20.6×vs this author's median67 527 views is typical
100Percentile for this authorof 7 recent posts
72.1×vs 100K–1M median19 302 views is typical
9.5× audienceReachviews ÷ followers
1.37%Engagement rateof viewers reacted